<DOC>
	<DOCNO>NCT01762488</DOCNO>
	<brief_summary>The purpose double-blind , randomize sham control study investigate blood pressure lower effect renal denervation catheter base ablation renal artery patient milder form treatment resistant hypertension . The effect blood pressure evaluate 24-hour ambulatory blood pressure measurement baseline 3 6 month follow . Secondary endpoint evaluation comprise hemodynamic assessment applanation tonometry cold pressor response .</brief_summary>
	<brief_title>Renal Denervation Treatment Resistant Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Systolic daytime ( 24 hourambulatory blood pressure measurement ) &gt; 135 mmHg &lt; 145 mmHg . Stable ( least 1 month plan change next 6 month ) antihypertensive therapy least 3 antihypertensive drug , include diuretic . Documented adherence present antihypertensive therapy Pregnancy Non compliance Heart failure ( NYHA Class IIIIV ) LV ejection fraction &lt; 50 % Renal insufficiency ( eGFR &lt; 30 ml/min ) Unstable coronary heart disease Coronary intervention within 6 month Myocardial infarction within 6 month Claudication Orthostatic syncope within 6 month Secondary hypertension ( except CKD ) Significant valvular heart disease Clinically significant biochemical abnormality ( electrolyte , haemoglobin , hepatic function , thyroid ) Second third degree AV block Macroscopic haematuria Renal artery anatomy suitable renal artery ablation ( Stenosis , diameter &lt; 4 mm , length &lt; 2 cm severe calcification ) Moderate/severe obstructive sleep apnoea ( AHI &gt; 15 ) CPAP treatment attempt</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Treatment Resistant Hypertension</keyword>
	<keyword>Renal Denervation</keyword>
</DOC>